Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni Fontecedro, Urania G. Dafni, R. N. Shah, Mary E.R. O'Brien, A. Pope and 17 more

Rank
43 of 3,211
Percentile
top 1.4%
Where
Annals of Oncology, 2020
Citations
271

From the 2020 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.